Original news and analysis on international IP policy
A subcommittee of the United States House of Representatives Energy and Commerce Committee today heard arguments for and against greater chemical regulation and trade secret protection in its review of the Toxic Substances Control Act (TSCA). The hearing also examined the Environmental Protection Agency (EPA)'s role in regulation.
The European Commission has prepared a draft regulation to implement an international protocol to prevent biopiracy, leading two non-governmental organisations to publish an opinion piece voicing concerns about it. The European Parliament is scheduled to review the draft on 4 July. A key concern is whether it would cover non-European genetic resources already in European collections.
A human embryonic stem cell patent held by the Wisconsin Alumni Research Foundation (WARF) should be invalidated, according to a legal filing made on 2 July by two public interest groups.
The Obama administration and academic and industry partners today announced their commitment to support the Materials Genome Initiative (MGI), a public-private endeavor whose aim is to reduce the time required to develop novel materials that can “fuel advanced manufacturing and bolster the 21st century American economy.”
A Harvard University professor known for advancing global development issues hails the merits of agricultural innovation, including biotechnologies, as the unique solution to food security.
Hong Kong – A recent conference here looked at the evolving biotechnology landscape in the Asia-Pacific region as well as prospects for networking and raising capital for early stage life science innovation.
Last Thursday, the United States Supreme Court overturned more than 30 years of precedents and ruled that isolated genes cannot be patented. They are products of nature and thus not patent-eligible subject matter, the court unanimously held in Assoc. for Molecular Pathology v. Myriad Genetics, Inc. This ruling puts the US at odds with most other nations, which allow genes to be patented. But because other major nations grant narrower gene patents, the net effect of Myriad will be to shift the US position on gene patents closer to that of other nations.
The United States Supreme Court came to a decision yesterday on the case of Association for Molecular Pathology v. Myriad Genetics, Inc., striking down Myriad’s patent on isolating human genes from the bloodstream.
The Association for Plant Breeding for the Benefit of Society (APBREBES) announced that its website is now online and its first newsletter has been issued.
The European Patent Office is continuing to grant patents on conventional plants despite demands from the European Parliament and the German Parliament that the patent office refrain from granting such patents, the coalition of non-governmental organisations called "No patents on seeds" said in a release.
The World Intellectual Property Organization is involved in activities aimed at facilitating technology transfer for green technologies, and research and development for neglected diseases, malaria and tuberculosis. At the request of member states, WIPO's Global Challenges Division gave a briefing this week on those activities.
The United States Supreme Court found today that a farmer who buys patented seeds may not reproduce them through planting and harvesting without the right holder's permission. The case, known as Bowman v. Monsanto, revolved around patent exhaustion. The Supreme Court was to decide whether patent exhaustion applied to patented seeds after their authorised sale.